Asymptomatic older patients of COVID-19 are one of the most difficult to identify - now, researchers find that delirium could be an indicator of the virus
New research explores the link between ethnicity and ESKD, which finds that Afro-Caribbean patients are four times more likely to undergo COVID hospitalisation.
New data from the Oxford COVID vaccine trial shows that the UK antidote is working well at Phase two, with defining percentages expected after Phase Three is complete.
A significant increase in online searches for "insomnia" signalled to researchers that the first COVID lockdown was hard-hitting on mental health in the US.
Office for Product Safety and Standards in the UK details their support of the frontline against the COVID-19 pandemic.
New research finds that bleeding and stroke are COVID-19 brain complications that are more frequent in people with diabetes and hypertension.
Fintan Grant, NHS Digital’s Programme Head for Medicines and Pharmacy charts the recent change in the speed of healthcare delivery in light of COVID-19 including the importance of digital solutions.
Dr Deborah Lee from Dr Fox Online Pharmacy discusses why we need to wear a face covering during the current COVID-19 pandemic, stating the evidence in this illuminating analysis.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group charts the influence of synthetic pesticides on human health and the global ecosystem.
Mhairi Brown, Policy and Public Affairs Manager for Action on Salt, stresses the need for Public Health England to implement a strict and ambitious salt reduction policy.
Eight days after the Pfizer vaccine results (90% effective) brought collective hope to the world, the Moderna vaccine has proven to be 95% effective at fighting COVID-19.
Loneliness during lockdown is one of the most universal afflictions - when researchers studied young adults in the US, they found "alarming" levels of COVID-19 depression.
Over 350 million people suffer from arthritis pain globally, which means significant levels of opiates are used to manage the condition - but what if there was a less addictive treatment?
Gino Martini, RPS Chief Scientist and the Science and Research Team at the Royal Pharmaceutical Society reflect on the role of pharmacy during COVID-19 in delivering accessible, safe and effective care for all.
European Public Health Association Executive Director, Dineke Zeegers Paget examines COVID-19 as a societal issue, not just a pandemic and argues that solidarity here is needed the most.
US and UK researchers examined ethnicity data in both countries, finding that Black and Asian people were twice as likely as white people to be infected by the virus - but why?
While the US and UK sealed their BioNTech and Pfizer vaccine deals within 24 hours of the new results, the European Commission took 3 days longer to secure their larger order of 300 million doses.
Nick Walsh, Sector Skills Development Officer at the Association of British Dispensing Opticians, shares his thoughts and predictions on technology and development in the eye care sector.
Yesterday, at 6:45am in the US, the Pfizer vaccine was revealed to be over 90% effective - so when will the successful drug be available for the UK to use?
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, China charts how to deal with dementia during the COVID-19 pandemic, starting with a helpful global and regional overview.